Abstract
This paper reports a novel drug delivery system based on TiO2 nanotube arrays (TNTs) modified with polydopamine (PDA) and Fe3+, which can load and release alendronate (NaAL), a drug for osteoporosis treatment, in a pH-responsive and near-infrared light-triggered manner. The samples were characterized by electron scanning microscopy(SEM/EDS), Fourier Transform infrared spectroscopy(FTIR), X-ray diffraction(XRD), X-ray Photoelectron Spectroscopy(XPS) and Thermogravimetry(TG). The drug release behavior of the samples was investigated under different pH and light conditions. The results showed that the TNTs-PDA-Fe3+ had improved drug loading capacity compared with the TNTs and TNTs-PDA. The drug release was pH-responsive and near-infrared light-triggered, the drug release from the sample with a pH of 4.6 was much greater than the pH of 11 and 7.4, and the photothermal conversion effificiency of TNTs-PDA-Fe3+-NaAL was 32.9 %. The drug release mechanism was attributed to the coordination bond between Fe3+ and NaAL, and the photothermal effect of the PDA. The cytotoxicity and biocompatibility of the samples were evaluated by MTT assay using mouse embryonic osteoblasts cells. The results indicated that the samples had no obvious cytotoxicity and could promote the cell proliferation and differentiation. The paper concludes that the TNTs-PDA-Fe3+-NaAL system is a potential implantable drug delivery platform for bone-related diseases.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
